MOTS-C - 40 mg (Mitochondrial Peptide)

1. AMPK Activation -Energy & Metabolic Regulation

MOTS-C activates AMPK (adenosine monophosphate-activated protein kinase), the master energy sensor of the cell. Through AMPK signaling, it helps:

• Increase cellular glucose uptake and fatty-acid oxidation
• Promote ATP generation in energy-deficient cells
• Enhance insulin sensitivity and glucose utilization
• Regulate lipid and carbohydrate metabolism

This mechanism restores metabolic homeostasis and supports mitochondrial efficiency in energy-demanding tissues such as skeletal muscle.

2. Mitochondrial Biogenesis & Stress Resistance

MOTS-C enhances mitochondrial signaling and turnover, promoting the generation of new, healthy mitochondria while removing damaged ones. It supports:

• Improved mitochondrial respiration and endurance capacity
• Activation of PGC-1α, a key regulator of mitochondrial biogenesis
• Protection against oxidative stress and DNA damage
• Improved cell survival under metabolic stress

These actions position MOTS-C as a powerful molecule for studying cellular longevity and metabolic resilience.

3. Insulin Sensitivity & Fat Utilization

In preclinical research, MOTS-C has been shown to:

• Enhance skeletal-muscle glucose uptake
• Improve insulin signaling in adipose and liver tissue
• Reduce lipid accumulation and improve fat oxidation
• Help regulate body-weight composition and energy expenditure

Together, these effects make MOTS-C a promising peptide in metabolic-disorder and obesity-related research.

4. Cellular Protection & Anti-Aging Pathways

MOTS-C also influences nuclear gene expression, signaling between the mitochondria and nucleus (retrograde communication). It activates stress-response genes and DNA-repair mechanisms, helping cells adapt to:

• Nutrient deprivation
• Oxidative damage
• Cellular senescence

This mitochondrial-to-nuclear signaling cascade is a key focus in longevity and age-related-decline research.

• Mitochondrial biogenesis and function studies
• Metabolic-syndrome and obesity-model research
• Insulin sensitivity and glucose-regulation experiments
• Cellular-stress and oxidative-damage investigations
• Longevity and anti-aging mechanism studies
• Exercise-performance and muscle-endurance models

MOTS-C -40 mg Lyophilized Peptide Powder

MOTS-C (40 mg) — Research Dosage Guidance

Mitochondrial Energy • Metabolic Enhancement • Cellular Repair

Reconstitution (Mixing)

• Add 3 ml Bacteriostatic Water to the vial
• Roll gently between palms (do not shake)
• Store reconstituted vial in the refrigerator (2–8 °C)

Concentration Calculation

40 mg ÷ 3 ml = 13.33 mg/ml

Every 10 units (0.1 ml) ≈ 1.33 mg (1 333 mcg)

Each 1 mg ≈ 7.5 units on a U-100 insulin syringe

Core Dosage Guidelines

Purpose: Mitochondrial energy, metabolic enhancement, and cellular repair research

Standard dose: 5–10 mg per injection

Frequency: 2–3× weekly

Advanced protocol: 10 mg daily (short metabolic cycles only)

Administration: Subcutaneous (abdomen, thigh, or upper arm)

Syringe Measurement Guide

Dose    Volume (ml)    Insulin Units
1.33 mg    0.10 ml    10 units
2 mg    0.15 ml    15 units
5 mg    0.38 ml    38 units
10 mg    0.75 ml    75 units

Targeted Research Protocols (Different Situations)
1.⁠ ⁠Metabolic Health & Insulin Sensitivity Research

• (Glucose handling, metabolic efficiency models)
• Dose: 5 mg
• Frequency: 2–3× weekly
• Duration: 6–8 weeks
• Notes: Foundational protocol with excellent tolerability

2.⁠ ⁠Fat-Loss & Body-Composition Research

• (AMPK activation, mitochondrial fat oxidation)
• Dose: 5–10 mg
• Frequency: 3× weekly
• Duration: 6–8 weeks
• Notes: Synergistic with NAD⁺, 5-Amino-1MQ, GLOW or KLOW Blend

3.⁠ ⁠Energy, Endurance & Performance Research

• (Cellular ATP production, muscular efficiency)
• Dose: 10 mg
• Frequency: 2–3× weekly
• Timing: Morning or pre-activity
• Duration: 4–6 weeks
• Notes: Non-stimulant energy support

4.⁠ ⁠Advanced Metabolic Reset Protocol

• (Short-term intensive mitochondrial signaling)
• Dose: 10 mg
• Frequency: Once daily
• Duration: 5–10 days only
• Notes: Advanced research protocol — follow with rest period

5.⁠ ⁠Longevity & Cellular Repair Research

• (AMPK signaling, mitochondrial biogenesis)
• Dose: 5 mg
• Frequency: 2× weekly
• Duration: 8 weeks
• Notes: Long-term mitochondrial support strategy

6.⁠ ⁠Maintenance / Long-Term Metabolic Support

• Dose: 5 mg
• Frequency: Once weekly
• Duration: Ongoing after a full cycle
• Notes: Maintains metabolic signaling with minimal exposure

Cycle Duration

• Typical cycle: 4–8 weeks
• Break: 2–4 weeks
• Advanced daily cycles: Max 10 days, followed by rest
• Repeat cycles: May be repeated depending on research goals

Key Research Benefits

• Boosts mitochondrial energy production
• Supports fat metabolism and insulin sensitivity
• Enhances endurance, recovery, and muscle performance
• Activates AMPK pathways linked to longevity
• Promotes cellular repair and metabolic resilience

Important Notes

Always use sterile needles and alcohol swabs

Do not reuse or share needles

Store reconstituted vial at 2–8 °C

For research use only

MOTS-C is a mitochondrial-derived peptide that activates AMPK and modulates metabolic, vascular, and immune-response pathways. Use caution or avoid in the following research contexts:

Pregnancy or lactation models (no safety data available)

Active cancer or tumor-bearing models (enhanced mitochondrial and metabolic activity may confound proliferation outcomes)

Uncontrolled hypertension or cardiovascular disease models (monitor vascular reactivity and hemodynamic parameters)

Severe hepatic or renal impairment (altered peptide clearance and metabolic handling)

Diabetes or hypoglycemia-prone models (AMPK activation may improve insulin sensitivity and lower glucose; monitor closely)

Autoimmune or inflammatory models (immune-modulatory effects may affect cytokine or inflammatory readouts)

MOTS-C is a well-tolerated, mitochondria-targeting research peptide supporting energy homeostasis, endurance, and metabolic balance. Side effects are rare, mild, and transient, usually limited to temporary fatigue, slight headache, or local itchy welts due to superficial administration. Symptoms typically resolve within 24–48 hours once the peptide diffuses or concentration is adjusted.